TryptaminesMigraine DisordersSumatriptanSerotonin Receptor AgonistsClonixinLoxapineFluoxetineAntidepressive Agents, Second-GenerationErgotamineNaproxenTreatment OutcomeProchlorperazineSerotonin Uptake InhibitorsDouble-Blind MethodDipyroneAntidepressive AgentsReceptors, Calcitonin Gene-Related PeptideCarbazolesSerotonin 5-HT1 Receptor AgonistsCitalopramTime FactorsAcute DiseaseAntipsychotic AgentsDepressive Disorder, MajorDose-Response Relationship, DrugLithium CarbonateMigraine with AuraRats, Sprague-DawleyBehavior, AnimalAnti-Anxiety AgentsHaloperidolAnalgesicsRecurrenceSertralineAdministration, OralDrug Administration ScheduleAntimanic AgentsCognitive TherapyCross-Over StudiesAzepinesPsychiatric Status Rating ScalesDisease Models, AnimalOxazolidinonesParoxetineDesipramineRanitidinePlacebosBenzodiazepinesRats, WistarPiperidinesPiperazinesBrainAnti-Inflammatory Agents, Non-SteroidalStrokeBipolar DisorderMotor ActivityClinical Trials as TopicDrug Therapy, CombinationSerotoninPain MeasurementAnalysis of VarianceBehavior TherapyItalyPyridinesVasoconstrictor AgentsPlant ExtractsInjections, IntravenousNeuroprotective AgentsTissue Plasminogen ActivatorDepressive DisorderCombined Modality TherapyRandomized Controlled Trials as TopicCells, CulturedHippocampusEnzyme InhibitorsSchizophreniaFibrinolytic AgentsSulfonamidesBrain IschemiaEthanolMice, Inbred C57BLRNA, MessengerNeuronsQuality of LifeLiverPhosphorylationMice, KnockoutInsulinSeverity of Illness IndexSignal TransductionProspective StudiesBlood PressureBody WeightCalcium